New Evidence Points to Potential of FGFR Inhibitors in Malignant...

Research suggests that some mesothelioma patients may be especially sensitive to drugs that inhibit this crucial signaling pathway.(PRWeb November 02, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14874826.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news